Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by SPCEO1on Apr 26, 2021 11:26am
86 Views
Post# 33066636

RE:RE:RE:Magic Mushrooms

RE:RE:RE:Magic MushroomsJsut did a quick tour of the MindMed website - they even have a section where you can purchase MindMed themed clothes, coffee mugs, etc. I am not sure TH needs that section on their new website, whenever that shows up, but it gives you an indication of how a company works to build a retail brand for its stock.

SPCEO1 wrote: So many small caps I look at do not have the potential that TH has yet sell at much higher valuations. TH needs to figure out how to tap into that rather than finding the few, like the Vancouver traded HAVN, to justify TH's inability to be part of the bull market despite the impressive successes it has had in NASH and cancer. 

stephanedodier wrote: HAVN Life Sciences Inc (HAVN.V) have a market cap of $68M CND, not all of them have stratospheric value.




<< Previous
Bullboard Posts
Next >>